Detalhe da pesquisa
1.
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648261